Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.24.2.u1
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Anti-Dilutive Securities Excluded from Computation of Diluted Earnings per Share
Securities that were anti-dilutive and therefore excluded from the computation of diluted net loss per share were as follows:

Three Months Ended Six Months Ended
  June 30, June 30,
2024 2023 2024 2023
Convertible Notes 10,811,884  11,253,471  10,811,884  11,361,458 
Non-vested RSUs and PSUs 2,140,560  2,206,000  2,140,560  2,206,000 
Options to purchase common stock 165,612  237,556  165,612  237,556 
Total anti-dilutive securities 13,118,056  13,697,027  13,118,056  13,805,014